what’s your IP challenge?
In late 2011, Galderma Laboratories and Supernus Pharmaceuticals brought suit against Sterne Kessler client Amneal Pharmaceuticals after Amneal submitted an ANDA seeking approval to market generic doxycycline capsules to compete with Galderma’s branded Oracea® drug product. Galderma and Supernus have alleged infringeme
...Patent infringement
Patent infringement
Patent Litigation
Patent infringement
Patent infringement, copyright infringement, misappropriation o
...Caliper Life Sciences, Inc. favorably settled two lawsuits with Carestream Health, Inc. In the first lawsuit, (Caliper Life Sciences, et al. v. Carestream Health, Civil Action No.: 4:10-cv-02079-PJH, (N.D. CA), Caliper, its subsidiary, Xenogen, and Stanford University alleged that Carestream’s marketing a
...Patent infringement
Patent infringement
Patent infringement
Patent infringement
Trademark infringement
Patent infringement
Patent infringement
Patent infringement
Patent Infringement
Patent infringement
Trademark infringement
Patent infringement
Copyright infringement
Patent infringement and trade dress infringement
Patent infringement
Patent infringement
Trademark infringement
...Patent infringement and trade dress infringement
Patent infringement
Patent Infringement
Patent infringement
Patent infringement
Trade dress infringement
Caliper Life Sciences, Inc. favorably settled two lawsuits with Carestream Health, Inc. In the first lawsuit, (Caliper Life Sciences, et al. v. Carestream Health, Civil Action No.: 4:10-cv-02079-PJH, (N.D. CA), Caliper, its subsidiary, Xenogen, and Stanford University alleged that Carestream’s marketing a
...Patent infringement
Patent infringement
Patent infringement
Patent infringement
Patent infringement
Patent infringement
Patent Infringement
In Microsoft v. i4i, the U.S. Supreme Court unanimously (8-0) affirmed the clear and convincing evidence standard for invalidating issued U.S. patents under Section 282 of the Patent Act (1952), supporting the position of Sterne Kessler client i4i. The case questioned the standard of proof necessary to invalidate
...The U.S. Court of Appeals for the Federal Circuit affirmed the December 15, 2010 dismissal of AstraZeneca Pharmaceuticals’ patent infringement lawsuit against Sterne Kessler client Glenmark Generics after it submitted an abbreviated new drug application (ANDA) with the FDA to market a generic version of its cholesterol low
...Patent Infringement
Trademark Infringement
Patent infringement
Patent Infringement
Patent Infringement